Cargando…

Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease

MicroRNAs (miRNAs) are attractive molecules to utilize as one of the blood-based biomarkers for neurodegenerative disorders such as Alzheimer’s disease (AD) because miRNAs are relatively stable in biofluid, including serum or plasma. To determine blood miRNA biomarkers for AD with next-generation se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hara, Norikazu, Kikuchi, Masataka, Miyashita, Akinori, Hatsuta, Hiroyuki, Saito, Yuko, Kasuga, Kensaku, Murayama, Shigeo, Ikeuchi, Takeshi, Kuwano, Ryozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282710/ https://www.ncbi.nlm.nih.gov/pubmed/28137310 http://dx.doi.org/10.1186/s40478-017-0414-z

Ejemplares similares

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)

Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin looping
por: Kikuchi, Masataka, et al.
Publicado: (2019)

Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid
por: Kasuga, Kensaku, et al.
Publicado: (2022)

Disruption of a RAC1-centred network is associated with Alzheimer’s disease pathology and causes age-dependent neurodegeneration
por: Kikuchi, Masataka, et al.
Publicado: (2020)

Genetics of Alzheimer’s disease: an East Asian perspective
por: Miyashita, Akinori, et al.
Publicado: (2022)

Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease
por: Miyashita, A, et al.
Publicado: (2014)

Identification of Unstable Network Modules Reveals Disease Modules Associated with the Progression of Alzheimer’s Disease
por: Kikuchi, Masataka, et al.
Publicado: (2013)

Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease
por: Kakuda, Nobuto, et al.
Publicado: (2012)

Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation
por: Ikeuchi, Takeshi, et al.
Publicado: (2011)

Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease
por: Sato, Yoshiaki, et al.
Publicado: (2015)

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data
por: Kikuchi, Masataka, et al.
Publicado: (2022)

AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
por: Mizuno, Satoshi, et al.
Publicado: (2012)

Biallelic COX10 Mutations and PMP22 Deletion in a Family With Leigh Syndrome and Hereditary Neuropathy With Liability to Pressure Palsy
por: Kuroha, Yasuko, et al.
Publicado: (2022)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease
por: Asanomi, Yuya, et al.
Publicado: (2021)

Novel CHP1 mutation in autosomal-recessive cerebellar ataxia: autopsy features of two siblings
por: Saito, Rie, et al.
Publicado: (2020)

A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer’s disease
por: Asanomi, Yuya, et al.
Publicado: (2019)

Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer’s disease: An autopsy-confirmed study
por: Morimoto, Satoru, et al.
Publicado: (2017)

Switched Aβ43 generation in familial Alzheimer’s disease with presenilin 1 mutation
por: Kakuda, Nobuto, et al.
Publicado: (2021)

Alterations in Glycerolipid and Fatty Acid Metabolic Pathways in Alzheimer's Disease Identified by Urinary Metabolic Profiling: A Pilot Study
por: Watanabe, Yumi, et al.
Publicado: (2021)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Incidence and extent of TDP-43 accumulation in aging human brain
por: Uchino, Akiko, et al.
Publicado: (2015)

Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons
por: Sumikura, Hiroyuki, et al.
Publicado: (2015)

Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk
por: Shigemizu, Daichi, et al.
Publicado: (2021)

Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus
por: Oikawa, Naoto, et al.
Publicado: (2015)

Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer’s disease brain
por: Dan, Ayaho, et al.
Publicado: (2013)

Molecular Network Analysis of the Urinary Proteome of Alzheimer's Disease Patients
por: Watanabe, Yumi, et al.
Publicado: (2019)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Oculopharyngodistal myopathy with coexisting histology of systemic neuronal intranuclear inclusion disease: Clinicopathologic features of an autopsied patient harboring CGG repeat expansions in LRP12
por: Saito, Rie, et al.
Publicado: (2020)

Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
por: Mori, Yukiko, et al.
Publicado: (2021)

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Iwata, Atsushi, et al.
Publicado: (2018)

Involvement of inflammation in the medial temporal region in the development of agitation in Alzheimer's disease: an in vivo positron emission tomography study
por: Yasuno, Fumihiko, et al.
Publicado: (2022)

Reduced CSF Water Influx in Alzheimer’s Disease Supporting the β-Amyloid Clearance Hypothesis
por: Suzuki, Yuji, et al.
Publicado: (2015)

Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis
por: Sato, Kenichiro, et al.
Publicado: (2019)

An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
por: Kizuka, Yasuhiko, et al.
Publicado: (2015)

A Patient with Fragile X-Associated Tremor/Ataxia Syndrome Presenting with Executive Cognitive Deficits and Cerebral White Matter Lesions
por: Kasuga, Kensaku, et al.
Publicado: (2011)

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review
por: Hosaka, Takashi, et al.
Publicado: (2017)

Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging
por: Fujishima, Motonobu, et al.
Publicado: (2017)

Heterogenous Genetic, Clinical, and Imaging Features in Patients with Neuronal Intranuclear Inclusion Disease Carrying NOTCH2NLC Repeat Expansion
por: Fitrah, Yusran Ady, et al.
Publicado: (2023)

Preparing for R501
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_gl92djv5kvre1edqnkdj76lb4g